SEC Tracker
Get the app

Petmed Express PETS

Petmed Express reported a net loss of $6.43 million for fiscal Q2 2027.

Petmed Express (PETS) filed a 10-Q with the SEC on Nov 10, 2026, 4:52 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $35.77 million for the three months ended Sep 30, 2026
  2. Net loss: $6.43 million for the three months ended Sep 30, 2026
  3. Diluted EPS: -$0.31 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $11.42 million at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Petmed Express files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

1 new legal mention

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange QoQ
Revenue$35.77M$41.02M−13%
Operating income and margin−$6.42M · -17.9%−$6.23M · -15.2%−3%, margin −2.7 pts
Net income−$6.43M−$6.15M−4.7%
Operating cash flow−$1.06M−$7.69M+86%
Cash$11.42M$13.08M−13%
New legal mentions (1)
  • That motion was granted and the court vacated the judgment as to the claims of one of the New York Plaintiff's (Plaintiff Dvornski). +1 more paragraph

Data on this page was fetched . The filing on SEC.gov is the record.